After that, increasing studies focused on the association between NOD2 polymorphisms and risks of various cancers including gastric cancer, colorectal cancer, endometrial cancer, breast cancer, ovarian cancer, laryngeal cancer and so on. The gene discussed is NOD2; the disease is laryngeal carcinoma.